US FDA grants priority review status to Celgene's ABRAXANE sNDA to treat ... pharmabiz.com ... is also approved in Canada, India, European Union/European Economic Area (EU/EEA), South Korea, China, Australia, Bhutan, United Arab Emirates, Nepal, New Zealand, Japan, Russia, Sri Lanka, and Argentina for the treatment of metastatic breast ... |
